LogicBio Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2017 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
LogicBio Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2017 to Q3 2022.
  • LogicBio Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$31K, a 88.5% increase year-over-year.
  • LogicBio Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$654K, a 39.7% increase year-over-year.
  • LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.07M, a 16.3% decline from 2020.
  • LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$922K, a 199% decline from 2019.
  • LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2019 was $935K, a 129% increase from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$654K -$31K +$239K +88.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$893K -$152K +$127K +45.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 -$1.02M -$213K +$52K +19.6% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$1.07M -$258K +$12K +4.44% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-04
Q3 2021 -$1.08M -$270K +$3K +1.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.09M -$279K -$11K -4.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$1.08M -$265K -$154K -139% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$922K -$270K -$237K -718% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-04
Q3 2020 -$685K -$273K -$388K -337% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$297K -$268K -$678K -165% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $381K -$111K -$554K -125% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $935K -$33K -$397K -109% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 $1.33M $115K +$195K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.14M $410K +$357K +674% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $780K $443K +$372K +524% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $408K $364K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$80K -$115K -329% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $53K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $71K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2017 $35K Jul 1, 2017 Sep 30, 2017 10-Q 2018-12-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.